Fatema Tuz Zohera

Fatema Tuz Zohera

Auto-generated profile, based on publicly available information

Fatema Tuz Zohera

International Islamic University Malaysia, Malaysia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2024 in Journal of Pharmacy
Verified
Journal Article
Open access
FZFatema Zohera
Fatema Zohera
FMFarahidah PROF. DR. FARAHIDAH Mohamed
Farahidah PROF. DR. FARAHIDAH Mohamed
AAAbul Kalam Azad
Abul Kalam Azad
MOMay Kyaw Oo
May Kyaw Oo
In past decades, nanomedicine has become a prominent area of focus within the discipline of nanotechnology, eliciting significant anticipation within the field of biomedical research. Scientists are creating unique nanoparticles for diagnosis, utilising techniques for imaging as well as therapy applications using medication delivery techniques. Mesoporous silica nanoparticles (MSNs), a recent addition to this area, serve as a sterling example of innovative nanostructures that offer distinctive and exceptional features. These features make them valuable for developing drug delivery systems with consistent and positive advancements in preclinical. MSNs efficiently encapsulate, control, and sometimes deliver biologic agents intracellularly for clinical use due to their distinct physicochemical characteristics, such as high porosity, large surface area, adjustable pore size and dimensions, good biocompatibility, and significant loading capacity. In this article, we discuss the latest advancements in fabrication, their presumed usefulness in delivering medications, and their application as diagnostic tools. It has been demonstrated that silica can store and release therapeutics, such as antibiotics, in a sustained and controlled manner. The desirable properties of MSNs have been further enhanced by modifying the surface of the siliceous frameworks through incorporating supramolecular assemblies and various metal species and their conjugates. These substantial advancements in innovative colloidal inorganic nanocontainers have driven researchers to explore their use in novel applications, such as stimuli (light/ultrasound/ magnetic)-responsive delivery-associated therapies with exceptional in vivo performance. This article provides a brief overview of the fabrication of siliceous frameworks and discusses significant advances in the engineering of MSNs. The precise control of the shape, dimension, homogeneity, and dispersity of MSNs is crucial, as these characteristics are critical quality attributes necessary for regulatory approval. Currently, explicit FDA guidelines for developing nanomaterial-based formulations intended for diagnostic or therapeutic purposes are lacking. Therefore, establishing standardised protocols and techniques for the synthesis and characterisation of nanoparticles, particularly for their use as theranostics, is essential for future commercial potential.

8 July 2025
Verified
Book Chapter
Closed access
FZFatema Tuz Zohera
Fatema Tuz Zohera
AAAbul Kalam Azad
Abul Kalam Azad
Alginate-based microbeads are promising carriers for targeted drug delivery due to their biocompatibility, biodegradability, and gel-forming capacity. Formed via ionotropic gelation with divalent cations, these microbeads protect labile drugs and enable sustained, controlled, and site-specific release. Tuning parameters like the M/G ratio and crosslinking density allows precise control of drug release kinetics and mechanical properties. Recent advances—including co-polymers, nanoparticles, and stimuli-responsive systems—have improved targeting, drug retention, and stability. Applications span gastrointestinal, colonic, and tumor-targeted therapies. With low toxicity and regulatory acceptability, alginate microbeads are suitable for oral, injectable, and localized administration. This review outlines recent developments, challenges, and future directions, highlighting alginate microbeads as a versatile platform in precision drug delivery.

8 July 2025
Verified
Book Chapter
Closed access
FZFatema Tuz Zohera
Fatema Tuz Zohera
WSWan Mohd Azizi Wan Sulaiman
Wan Mohd Azizi Wan Sulaiman
AAAbul Azad
Abul Azad
Biodegradable polymers play a pivotal role in modern drug delivery by enabling sustained and controlled release, reducing systemic toxicity, and improving patient adherence. These materials degrade into non-toxic byproducts, eliminating the need for surgical removal and supporting various formulations like nanoparticles, hydrogels, and implants. This review explores natural and synthetic polymers, their degradation mechanisms, and innovations such as stimuli-responsive systems and targeted delivery. Applications span oncology, infectious diseases, cardiovascular therapy, diabetes, and tissue engineering. Key challenges include consistent drug loading, initial burst control, and manufacturing scalability. The paper also highlights safety, regulatory considerations, and future directions involving smart materials and biosensor integration. Biodegradable polymers continue to shape the future of personalized and regenerative medicine.